📋 History
- 50-year-old obese male
- Known Type 2 Diabetes Mellitus
- Known Hypertension
- BP: 160/100 mmHg
- HbA1C: 8.5% (poor control)
🔍 Examination
- Obese
- Blood pressure elevated (160/100 mmHg)
- No edema
- No visible haematuria
🧪 Investigations
- Serum Creatinine: 1.4 mg/dL
- Urinalysis: 1+ Proteinuria
- Urine RBC: Absent
- HbA1C: 8.5%
❓ MCQ Question
What is the most appropriate first-line antihypertensive in this patient?
A. AmlodipineB. Atenolol
C. Enalapril (ACE Inhibitor)
D. Hydrochlorothiazide
E. Prazosin
📝 Brief Case Summary
Middle-aged obese diabetic patient with poorly controlled hypertension, mild renal impairment, and proteinuria without haematuria suggestive of early diabetic kidney disease.
✅ Click for Answer
Show Answer
Answer: C. Enalapril (ACE Inhibitor)
📚 Answer Explanation
ACE inhibitors are the preferred first-line antihypertensive agents in patients with diabetes and proteinuria because they:
- Reduce intraglomerular pressure
- Decrease proteinuria
- Slow progression of diabetic nephropathy
- Provide cardiovascular protection
- Improve long-term renal outcomes
❌ Why Not Others?
- Amlodipine: Controls BP but less renal protective.
- Atenolol: Not first-line for diabetic nephropathy.
- Hydrochlorothiazide: Useful add-on, not best initial renal-protective choice.
- Prazosin: Not recommended as first-line therapy.
🩺 Five Brief Case Scenarios
- Diabetic patient with microalbuminuria → ACE inhibitor preferred.
- Diabetic CKD with proteinuria → ACEI/ARB indicated.
- Type 1 diabetes with albuminuria → ACE inhibitor beneficial.
- Hypertensive diabetic with rising creatinine → assess nephropathy and RAAS blockade.
- Proteinuric CKD without haematuria → consider diabetic nephropathy.
🧠 Pathophysiology Simplified
- Chronic hyperglycemia damages glomerular capillaries.
- Glomerular basement membrane thickens.
- Protein leaks into urine.
- Progressive nephron loss occurs.
- ACE inhibitors reduce glomerular hypertension and protein loss.
🔎 Physical Examination Pearls
- Measure BP accurately.
- Assess BMI and central obesity.
- Look for edema.
- Check diabetic foot changes.
- Screen for hypertensive retinopathy.
🧪 Investigations: Choosing Wisely
- Urine Albumin-Creatinine Ratio (UACR)
- Serum Creatinine & eGFR
- HbA1C monitoring
- Electrolytes before and after ACEI
- Lipid profile
- Fundoscopy
💊 Management
- Start ACE inhibitor (or ARB if intolerant)
- Optimize glycemic control
- Target BP <130/80 mmHg in proteinuric CKD
- Weight reduction
- Salt restriction
- Exercise regularly
- Consider SGLT2 inhibitor if eligible
🔄 Differential Diagnosis
- Diabetic nephropathy
- Hypertensive nephrosclerosis
- Obesity-related glomerulopathy
- Chronic glomerulonephritis
- IgA nephropathy
⚠ Clinical Pitfalls
- Ignoring mild proteinuria.
- Using only BP-lowering drugs without renal protection.
- Failure to monitor potassium after ACEI.
- Delayed CKD screening in diabetics.
- Poor glycemic control accelerating nephropathy.
💎 Clinical Pearls
- Proteinuria changes antihypertensive choice.
- ACEI/ARB provides kidney protection beyond BP control.
- Microalbuminuria is an early marker of diabetic nephropathy.
- Good glycemic control slows CKD progression.
- Monitor creatinine after ACE inhibitor initiation.
📈 Monitoring & Follow-up
- BP every visit
- HbA1C every 3 months
- UACR every 6–12 months
- Serum Creatinine and Potassium after ACEI initiation
- Annual retinal screening
- Cardiovascular risk assessment
❔ FAQ (Questions with Answers)
1. Why is proteinuria important?
It indicates kidney damage and predicts CKD progression.
2. Why choose ACE inhibitors?
They reduce proteinuria and protect kidney function.
3. What if ACE inhibitors cause cough?
Switch to an ARB.
4. What is microalbuminuria?
Urinary albumin excretion of 30–300 mg/day.
5. Why monitor potassium?
ACE inhibitors may cause hyperkalemia.
6. What BP target is recommended?
Generally below 130/80 mmHg in proteinuric CKD.
7. Can creatinine rise after ACEI?
A mild rise is expected and often acceptable.
8. What is diabetic nephropathy?
Kidney damage caused by chronic diabetes.
9. Why check eGFR?
To stage kidney disease.
10. What lifestyle changes help?
Weight loss, exercise, and salt restriction.
11. Why control HbA1C?
To slow renal deterioration.
12. What is the role of SGLT2 inhibitors?
They provide renal and cardiovascular protection.
13. Is amlodipine contraindicated?
No, but it lacks the same renal protection.
14. How often should urine albumin be checked?
At least annually.
15. What is the biggest long-term risk?
Progression to chronic kidney disease and cardiovascular disease.
📖 Key Guidelines & References
- KDIGO Clinical Practice Guideline for CKD
- ADA Standards of Care in Diabetes
- ESC Hypertension Guidelines
- ACC/AHA Hypertension Guideline
- NICE CKD and Hypertension Guidance
🔍Keywords
Diabetic nephropathy, ACE inhibitor, Enalapril, Proteinuria, Hypertension in diabetes, CKD management, Microalbuminuria, Diabetes kidney disease, Renal protection, First-line antihypertensive
📚 Internal Medicine Quiz
Follow our Facebook page for more Internal Medicine MCQs, Clinical Cases, FCPS Preparation & Exam Pearls.
🔗 Visit Internal Medicine Quiz Facebook Page🫀 Cardiology 🫁 Respiratory 🧠 Neurology 🩸 Hematology 🧪 Nephrology 🦠 Gastroenterology 🏥 Hepatology 🦴 Rheumatology 💉 Endocrinology 🩺 ABG 🧩 Psychiatry ☠️ Poisoning 🌿 Environment
🏠 Back to Home | 📬 Contact Us | 📋 About Us